NATCO Pharma shares tumbled 10% on Friday, extending a two-day slump to 28% after weak Q3 results and a target price cut by Nuvama. Profit ...

The third quarter earnings season sees key companies like Ashok Leyland, Siemens, and others announcing results. Ashok Leyland is predicted...

Brokerage Nomura upheld a neutral rating on Persistent Systems, while Investec continues to advocate a buy stance on Natco Pharma and has i...

Mayuresh Joshi shares insights on pharma and telecom sectors, focusing on key players like Sun Pharma, Dr Reddy's, Bharti Hexacom, and Exid...

Institutional investors such as foreign portfolio investors and mutual funds have increased their stakes in at least 20 Indian stocks in th...

Natco’s recent diversification of its exports to markets like Brazil, Canada, China, is doing well and is expected to do so in future as we...

Reported profits are expected to have declined 19 per cent to Rs 982 million.

Brokerage sees coronavirus crisis as a positive for companies like Granules India and Natco.

Caplin Point Laboratories’ 10-year return is mindboggling at 22,300 per cent. This stock has gained 23 per cent after falling 21 per cent i...

The USFDA granted the highest-ever approvals in a single quarter with 246 clearances.

The BSE Healthcare index was flat in 2017 compared to 28 per cent rise in Sensex.

The pharma company reported a five-fold jump in December quarter profit.

The growth potential was determined by comparing the consensus estimates for the next 12 months with the historical 12-month value, the rep...

The company showed a very strong performance over the last 12 months. In FY16, the company posted a top line of almost Rs 1170 crore and a ...

JP Morgan said Dish TV's adjusted EV/ EBITDA multiple is at 9x FY17E earnings and 7x FY18E earnings which they consider cheap.

Ambit Capital retained its sell rating on Balkrishna Industries with a target price of Rs 600 citing weak global off-highway tyre demand.

Investors lapped up shares of mid-cap pharma firms on Wednesday as weakness in the broader market prompted them to focus on these bets.